About NGL Fine Chem
NGL Fine Chem is a company based in Mumbai (India) founded in 1981.. The company has 523 employees as of March 31, 2024. NGL Fine Chem operates in a competitive market with competitors including Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
- Headquarter Mumbai, India
- Employees 523 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ngl Fine-Chem Ltd.
-
Annual Revenue
$42.99 M (USD)8.73as on Mar 31, 2024
-
Net Profit
$2.47 M (USD)-48.87as on Mar 31, 2024
-
EBITDA
$4.07 M (USD)-35.1as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
523
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NGL Fine Chem
NGL Fine Chem is a publicly listed company on the NSE with ticker symbol NGLFINE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of NGL Fine Chem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NGL Fine Chem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NGL Fine Chem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ngl Fine Chem Comparisons
Competitors of NGL Fine Chem
NGL Fine Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ngl Fine Chem
Frequently Asked Questions about NGL Fine Chem
When was NGL Fine Chem founded?
NGL Fine Chem was founded in 1981.
Where is NGL Fine Chem located?
NGL Fine Chem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
How many employees does NGL Fine Chem have?
As of Mar 31, 2024, the latest employee count at NGL Fine Chem is 523.
What is the annual revenue of NGL Fine Chem?
Annual revenue of NGL Fine Chem is $42.99M as on Mar 31, 2024.
What does NGL Fine Chem do?
NGL Fine Chem is engaged in the development and manufacture of APIs, intermediates and formulations for human and veterinary health. Their service portfolio includes custom synthesis, process development and manufacturing. They claim to expertise in multi-stage organic synthesis of APIs and fine chemicals. The company is WHO GMPand ISO 9001:2008 certified and has kilo and pilot labs and 3 manufacturing facilities. Their human API portfolio includes around 20 drug substances. The company was part of the Best under a Billion list of the top 200 publicly traded companies in the Asia-Pacific region, among 7 other Indian companies in 2016.
Who are the top competitors of NGL Fine Chem?
NGL Fine Chem's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Is NGL Fine Chem publicly traded?
Yes, NGL Fine Chem is publicly traded on NSE under the ticker symbol NGLFINE.
What is NGL Fine Chem's ticker symbol?
The ticker symbol of NGL Fine Chem is NGLFINE on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.